Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia (B.B., H.K., A.M., G.E., M.S.M.) and Georgia Cancer Center (P.-C.L., A.S.A.), Augusta University, Augusta, Georgia; and Department of Medicine, University of Perugia, Perugia, Italy (C.M., C.R.).
Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia (B.B., H.K., A.M., G.E., M.S.M.) and Georgia Cancer Center (P.-C.L., A.S.A.), Augusta University, Augusta, Georgia; and Department of Medicine, University of Perugia, Perugia, Italy (C.M., C.R.)
J Pharmacol Exp Ther. 2018 Dec;367(3):483-493. doi: 10.1124/jpet.118.251371. Epub 2018 Oct 9.
The glucocorticoid-induced leucine zipper (GILZ) mediates anti-inflammatory effects of glucocorticoids. Acute kidney injury (AKI) mobilizes immune/inflammatory mechanisms, causing tissue injury, but the impact of GILZ in AKI is not known. Neutrophils play context-specific proinflammatory [type 1 neutrophil (N1)] and anti-inflammatory [type 2 neutrophil (N2)] functional roles. Also, regulatory T lymphocytes (Tregs) and regulatory T-17 (Treg17) cells exert counterinflammatory effects, including the suppression of effector T lymphocytes [e.g., T-helper (Th) 17 cells]. Thus, utilizing cell preparations of mice kidneys subjected to AKI or sham operation, we determined the effects of GILZ on T cells and neutrophil subtypes in the context of its renoprotective effect; these studies used the transactivator of transcription (TAT)-GILZ or the TAT peptide. AKI increased N1 and Th-17 cells but reduced N2, Tregs, and Treg17 cells in association with increased interleukin (IL)-17 but reduced IL-10 cells accompanied with the disruption of mitochondrial membrane potential ( ) and increased apoptosis/necrosis compared with sham kidneys. TAT-GILZ, compared with TAT, treatment reduced N1 and Th-17 cells but increased N2 and Tregs, without affecting Treg17 cells, in association with a reduction in IL-17 cells but an increase in IL-10 cells; TAT-GILZ caused less disruption of and reduced cell death in AKI. Importantly, TAT-GILZ increased perfusion of the ischemic-reperfused kidney but reduced tissue edema compared with TAT. Utilizing splenic T cells and bone marrow-derived neutrophils, we further showed marked reduction in the proliferation of Th cells in response to TAT-GILZ compared with response to TAT. Collectively, the results indicate that GILZ exerts renoprotection accompanied by the upregulation of the regulatory/suppressive arm of immunity in AKI, likely via regulating cross talk between T cells and neutrophils.
糖皮质激素诱导亮氨酸拉链(GILZ)介导糖皮质激素的抗炎作用。急性肾损伤(AKI)动员免疫/炎症机制,导致组织损伤,但 GILZ 在 AKI 中的影响尚不清楚。中性粒细胞发挥特定的促炎[1 型中性粒细胞(N1)]和抗炎[2 型中性粒细胞(N2)]功能作用。此外,调节性 T 淋巴细胞(Tregs)和调节性 T-17(Treg17)细胞发挥抗炎作用,包括抑制效应 T 淋巴细胞[例如,辅助性 T 细胞(Th)17 细胞]。因此,利用 AKI 或假手术小鼠肾脏的细胞制剂,我们确定了 GILZ 在其肾保护作用的背景下对 T 细胞和中性粒细胞亚型的影响;这些研究使用转录激活因子(TAT)-GILZ 或 TAT 肽。与 sham 肾脏相比,AKI 增加了 N1 和 Th-17 细胞,但减少了 N2、Tregs 和 Treg17 细胞,伴随着白细胞介素(IL)-17 细胞的增加,但 IL-10 细胞的减少,同时伴随着线粒体膜电位()的破坏和细胞凋亡/坏死的增加。与 TAT 相比,TAT-GILZ 治疗减少了 N1 和 Th-17 细胞,但增加了 N2 和 Tregs,而不影响 Treg17 细胞,伴随着 IL-17 细胞的减少和 IL-10 细胞的增加;TAT-GILZ 导致 AKI 中 的破坏和细胞死亡减少。重要的是,与 TAT 相比,TAT-GILZ 增加了缺血再灌注肾脏的灌注,但减少了组织水肿。利用脾 T 细胞和骨髓来源的中性粒细胞,我们进一步表明,与 TAT 相比,TAT-GILZ 显著减少了 Th 细胞的增殖。总的来说,这些结果表明,GILZ 发挥肾保护作用,同时上调 AKI 中免疫的调节/抑制臂,可能通过调节 T 细胞和中性粒细胞之间的串扰。